Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases

scientific article

Neuroendocrine markers in adenocarcinomas: an investigation of 356 cases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V9.I4.858
P932PMC publication ID4611465
P698PubMed publication ID12679948
P5875ResearchGate publication ID283588737

P2093author name stringGen-You Yao
Xiao-Qing Chen
Mao-De Lai
Ji-Lin Zhou
Pei-Hui Chen
P2860cites workA new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumoursQ28359544
Tumor markers in neuroendocrine tumorsQ34001693
Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumoursQ34474274
Classification of gastric neuroendocrine tumors and its clinicopathologic significanceQ36397178
Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literatureQ37716893
Neuroendocrine tumours of the gut: long-term therapy with the somatostatin analogue SMS 201-995.Q39546202
Somatostatin and the lungQ40625448
Neuroendocrine differentiation in prostatic carcinoma: an updateQ41019553
Clinical significance of neuroendocrine carcinoma of the breastQ43836880
Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumorsQ44104432
Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literatureQ47758479
Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995.Q52828506
Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.Q53399228
A case of small cell carcinoma of the stomachQ64050396
Argyrophilia and granin (chromogranin/secretogranin) expression in female breast carcinomas. Their relationship to survival and other disease parametersQ67536840
Neuroendocrine carcinoid tumours of the breast: A variant of carcinoma with neuroendocrine differentiationQ67680724
Spindle-Cell Argyrophilic Mucin-Producing Carcinoma of the Breast Histological, Ultrastructural, and Immunohistochemical Studies of Two CasesQ67693009
Neuro-endocrine type of gastric carcinoma. Immunohistochemical and electron microscopic studies of 100 casesQ68157661
Octapeptide analogues of somatostatin inhibit the clonal growth and vasoactive intestinal peptide-stimulated cyclic AMP formation in human small cell lung cancer cellsQ68332880
Radiosensitivity related to neuroendocrine and endodermal differentiation in lung carcinoma linesQ69048742
Neuroendocrine differentiation in carcinomas of the breast: a study of 51 casesQ69222280
In vitro and in vivo inhibition of human small cell lung carcinoma (NCI-H69) growth by a somatostatin analogueQ69919083
Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumourQ70390673
Plasma chromogranin A in prostatic carcinoma and neuroendocrine tumorsQ71975836
Neuroendocrine-like differentiation in patients with pancreatic carcinomaQ73370155
[Gastric neuroendocrine tumor]Q74588079
Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodiesQ77102007
Evaluation of chromogranin A expression in serum and tissues of breast cancer patientsQ77577181
Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumorQ77631689
Studies on the DNA content of breast carcinoma cells with neuroendocrine differentiationQ77899862
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectadenocarcinomaQ356033
P304page(s)858-861
P577publication date2003-04-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleNeuroendocrine markers in adenocarcinomas: an investigation of 356 cases
P478volume9

Reverse relations

cites work (P2860)
Q36938703A biopsychosocial approach to examining tobacco-related health disparities among racially classified social groups
Q37149103ACTH-Producing Breast Cancer: A Patient Report
Q38905385Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer
Q34975445Clonality analysis of neuroendocrine cells in gastric adenocarcinoma
Q33195833Effects of bile acids on proliferation and ultrastructural alteration of pancreatic cancer cell lines
Q36502545Effects of daidzein on estrogen-receptor-positive and negative pancreatic cancer cells in vitro
Q36603956Genes involved in neuroendocrine tumor biology
Q43093716Immunostaining of gastric cancer with neuroendocrine differentiation: Reg IV-positive neuroendocrine cells are associated with gastrin, serotonin, pancreatic polypeptide and somatostatin
Q51838966Neuroendocrine carcinoma of the stomach: clinicopathological and immunohistochemical evaluation.
Q33908612Neuroendocrine differentiation is a prognostic factor for stage II poorly differentiated colorectal cancer
Q26778012Neuroendocrine differentiation: The mysterious fellow of colorectal cancer
Q47404152Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction
Q64917588Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?
Q35613016Pancreatic cancer - a continuing challenge in oncology
Q64071231Prognostic Threshold of Neuroendocrine Differentiation in Gastric Carcinoma: a Clinicopathological Study of 945 Cases
Q38189266Prognostic significance of neuroendocrine differentiation in colorectal adenocarcinoma after radical operation: a meta-analysis
Q81408260Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications
Q83878452[Mixed endocrine tumors]

Search more.